---
title: 'EASL 2024 Research: Presentation by Arun J. Sanyal, MBBS, MD'
description: >-
  Read the latest news on regulatory-grade real-world evidence: EASL 2024
  Research: Presentation by Arun J. Sanyal, MBBS, MD.
date: '2024-06-11'
category: News
tags:
  - Conference Presentation
  - R&D
  - Care
  - Cross-cutting
  - General
canonical_url: >-
  https://www.pedestalhealth.com/resources/news/conference-presentation/easl-2024-research-presentation-by-arun-j-sanyal-mbbs-md/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: easl-2024-research-presentation-by-arun-j-sanyal-mbbs-md
id: 4Z6ONXz9IWX3OTI3iqOU3D
contentType: article
---

Co-chair of the TARGET-NASH steering committee, Arun J. Sanyal, MBBS, MD, helped author a new Target RWE study which was presented at EASL 2024 titled *“A Prospective Assessment of Disease Progression Impact on Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.”*

Focusing on metabolic dysfunction-associated stereotactic liver disease (MASLD), the study investigated disease progression impact on patient-reported outcomes (PROs) and highlights the increased burden on patients as the disease advances. Watch this video presentation by Dr. Sanyal highlighting the important study: